Lionhunter Capital Management’s Merck MRK Stock Holding History

Lionhunter Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.9M	Buy	+14,789	New	+$1.73M	0.86%	37

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Lionhunter Capital Management's MRK Position: Q2 2026 in Review

Lionhunter Capital Management opened a new position in Merck (MRK) in Q2 2026: 14,789 shares worth $1.9M. The stake represents 0.86% of the portfolio and ranks #37 among its holdings.

3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Lionhunter Capital Management held 14,789 shares of Merck worth $1.9M as of Q2 2026.
Merck was a new Lionhunter Capital Management position in Q2 2026.
Merck made up 0.86% of Lionhunter Capital Management's portfolio in Q2 2026, its #37 holding.
3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lionhunter Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.